ReviewCancer biology & therapy2017
Clinicopathological characteristics and experience in the treatment of giant retroperitoneal liposarcoma: A case report and review of the literature.
Review in Cancer biology & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- A systematic review of margin status in retroperitoneal liposarcomas: Does the R0 margin matter?Frontiers in oncology · 2022Pooled it
- Article
- Review
- Retroperitoneal multiple giant liposarcoma: a case report.Frontiers in surgery · 2025Article
- The independent prognostic nomogram models for primary and recurrent retroperitoneal liposarcoma: a population-based cohort study.Frontiers in medicine · 2025Article
- Giant retroperitoneal liposarcoma with multiple organ involvement: a case report and literature review.BMC nephrology · 2024Review
- A Case of a Giant Liposarcoma at Binh Dan Hospital.Cureus · 2024Article
- Giant retroperitoneal well differentiated liposarcoma: A case report and literature review.International journal of surgery case reports · 2023Article
- Impact of retroperitoneal tumors on the digestive tract (Review).Experimental and therapeutic medicine · 2022Review
- Giant retroperitoneal dedifferentiated liposarcoma mimicking ovarian cancer: A case report.Gynecologic oncology reports · 2022Article
- Giant Retroperitoneal Liposarcoma: Correlation Between Size and Risk for Recurrence.World journal of oncology · 2022Review
- Retroperitoneal Liposarcoma: The Giant Type.Journal of medical cases · 2022Article
- Giant retroperitoneal liposarcoma surgical management.Annals of the Royal College of Surgeons of England · 2022Article
- Survival of a patient with multiple-recurrent giant retroperitoneal dedifferentiated liposarcoma for 15 years: A case report.Frontiers in surgery · 2022Article
- Case report and literature review: Conversion surgery for initially unresectable huge retroperitoneal liposarcoma after preoperative radiotherapy.Frontiers in oncology · 2022Article
- A Successful En Bloc Excision of a Giant Retroperitoneal Liposarcoma With Distal Splenopancreatectomy.Cureus · 2021Article
- Perioperative strategy and outcome in giant retroperitoneal dedifferentiated liposarcoma-results of a retrospective cohort study.World journal of surgical oncology · 2020Article
- Giant retroperitoneal liposarcoma with a maximum diameter of 37 cm: a case report and review of literature.Annals of translational medicine · 2020Article
- Recurrent giant retroperitoneal liposarcoma with 10 years follow up. Case report and review of literature.International journal of surgery case reports · 2020Article
- A recurrent giant retroperitoneal myxoid liposarcoma: a case report and literature review.Translational cancer research · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retroperitoneal liposarcoma (RPLS) is a rare tumor, especailly those over 20 kg that are called "giant liposarcoma," whose characteristics and treatments remain relatively unknown. Herein, we report a giant RPLS measuring 65 × 45 × 30 cm in diameter and 31 kg in weight, which we successfully performed complete excision through interdisciplinary cooperation. The patient had an uneventful postoperative course and was discharged without complications. Afterwards he underwent radiotherapy and had no evidence of tumor recurrence or symptoms of metastasis at 3-month CT scan and 8-month follow-up. We also first review the 13 cases reported in literature published in PubMed regarding giant RPLS. Giant RPLS commonly occurs in adults aged 40-60 y and presents atypical clinical manifestations. CT scan is the most useful examination and preoperative biopsy is controversial. Complete surgical resection still remains the principal treatment. Giant RPLS can also be removed, even reach to R0 excision, by a multidisciplinary team in a specialized center after meticulous planning even though its gigantic tumor size. Local radiotherapy following surgery may improve the rate of recurrence. Besides, closely follow-up and routine examinations are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.